Novartis AG NVS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -69.40% | -19.23% | -12.48% | -14.51% | 23.17% |
| Total Depreciation and Amortization | 4.05% | 3.45% | 3.39% | 0.86% | 8.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 940.31% | 10.54% | -56.94% | 106.88% | -71.20% |
| Change in Net Operating Assets | -131.77% | -111.66% | 47.43% | -794.90% | 29.13% |
| Cash from Operations | -16.25% | -11.73% | 0.85% | -46.01% | 4.53% |
| Capital Expenditure | -10.73% | 3.02% | -36.22% | -9.14% | -10.28% |
| Sale of Property, Plant, and Equipment | -- | 2,500.00% | -50.00% | -97.87% | 0.00% |
| Cash Acquisitions | -1,092.47% | -64.84% | -- | -172.07% | -60.34% |
| Divestitures | 165.63% | 663.64% | 50.00% | -105.49% | -1,014.29% |
| Other Investing Activities | 18.00% | 45.80% | 12.11% | 85.49% | -11,566.67% |
| Cash from Investing | -103.02% | -38.43% | -3,656.36% | 30.63% | -129.95% |
| Total Debt Issued | -- | 157.65% | 1,998.02% | 21,458.33% | -96.32% |
| Total Debt Repaid | -18.89% | 87.00% | 91.47% | -2,147.56% | 44.31% |
| Issuance of Common Stock | -- | -30.00% | -- | -- | -60.00% |
| Repurchase of Common Stock | 26.24% | 55.82% | 30.96% | 46.42% | 19.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -15.53% | -16.20% | -- | -- |
| Other Financing Activities | -90.91% | 68.84% | 239.13% | 3.13% | 151.16% |
| Cash from Financing | 11.65% | 61.25% | 141.87% | 156.17% | -630.10% |
| Foreign Exchange rate Adjustments | -77.27% | -104.71% | -142.78% | 111.46% | -112.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.76% | 280.24% | -3.76% | 187.40% | -49.18% |